Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 4230-4235

  Fleming, Sherry D ^a,b   Monestier, Marc ^c   Tsokos, George C ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; HISTONE ANTIBODY; ICOSANOID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LEUKOTRIENE B4; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE ISCHEMIA; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 4644229819     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.4230     Document Type: Article

References (42)

1. Fleming, S. D., D. Mastellos, G. Karpel-Massler, T. Shea-Donohue, J. D. Lambris, and G. C. Tsokos. 2003. C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin. Immunol. 108:263.
2. Fleming, S. D., J. Anderson, F. Wilson, T. Shea-Donohue, and G. C. Tsokos. 2003. C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin. Immunol. 105:55.
3. Simpson, R., R. Alon, L. Kobzik, C. R. Valeri, D. Shepro, and H. B. Hechtman. 1993. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann. Surg. 218:444.
4. Hernandez, L. A., M. B. Grisham, B. Twohig, K. E. Arfors, J. M. Harlan, and D. N. Granger. 1987. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol. 253:H699.
5. Rehrig, S., S. D. Fleming, J. Anderson, J. M. Gutheridge, J. Rakstang, C. McQueen, V. M. Holers, G. C. Tsokos, and T. Shea-Donohue. 2001. Complement inhibitor, Crry-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 167:5921.
6. Austen, W. G., C. Kyriakides, J. Favuzza, Y. Wang, L. Kobzik, F. D. Moore, and H. B. Hechtman. 1999. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 126:343.
7. Fruchlerman, T. M., D. A. Spain, M. A. Wilson, P. D. Harris, and R. N. Garrison. 1998. Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124:782.
8. Hill, J., T. F. Lindsay, F. Ortiz, C. G. Yeh, H. B. Hechtman, and F. D. Moore. 1992. Soluble complement receptor type I ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J. Immunol. 149:1723.
9. Karpel-Massler, G., S. D. Fleming, M. Kirschfink, and G. C. Tsokos. 2003. Human C1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury. J. Surg. Res. 115:247.
10. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169:2126.
11. Williams, J. P., T. T. V. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore, M. C. Carroll, and H. B. Hechtman. 1999. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86:938.
12. Zhang, M., M. Xu, J. Austen, J. Hermingoda, W. Caine, L. Kobzik, H. B. Hechtman, F. D. Moore, and M. C. Carroll. 2001. Natural IgM mediated ischemia/reperfusion injury. Clin. Immunol. 99:143.
13. Stahl, G. L., Y. Xu, L. Hao, M. Miller, J. A. Buras, M. Fung, and H. Zhao. 2003. Role for the alternate complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162:449.
14. Weiser, M. R., J. P. Williams, F. D. Moore, L. Kobzik, M. Ma, H. B. Hechtman, and M. C. Carroll. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:2343.
15. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156.
16. Ochsenbein, A. F., and R. M. Zinkernagel. 2000. Natural antibodies and complement link innate and acquired immunity. Immunol. Today 21:624.
17. Theofilopoulos, A. N. Murine models of lupus. In Systemic Lupus Erythematosus. R. G. Lahita, ed. Churchill Livingstone, New York, p. 121.
18. Manheimer-Lory, A. J., G. Zandman-Goddard, A. Davidson, C. Aranow, and B. Diamond. 1997. Lupus-specific antibodies reveal an altered pattern of somatic mutation. J. Clin. Invest. 100:2538.
19. Li, Y., H. Li, D. Ni, and M. Weigert. 2002. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med. 196:1543.
20. Monestier, M., P. Decker, J.-P. Briand, J. L. Gabriel, and S. Muller. 2000. Molecular and structural properties of three autoimmune IgG monoclonal antibodies to histone H2B. J. Biol. Chem. 275:13558.
21. 2-glycoprotien I and cardiolipin. J. Immunol. 156:2631.
22. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
23. Eisenberg, R. A., S. Y. Craven, C. L. Fisher, S. C. Morris, R. Rapoport, D. S. Pisetsky, and P. L. Cohen. 1989. The genetics of autoantibody production in MRL/lpr lupus mice. Clin. Exp. Rheumatol. 7(Suppl. 3):S35.
24. Warren, R. W., D. M. Sailstad, and D. S. Pisetsky. 1984. Monoclonal rheumatoid factors from B6-lpr/lpr mice. Clin. Exp. Immunol. 58:731.
25. Zhang, M., W. G. Austen, I. Chiu, E. M. Alicot, R. Humg, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore, and M. C. Carroll. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101:3886.
26. Losman, J. J., T. M. Fasy, K. E. Novick, and M. Monestier. 1993. Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int. Immunol. 5:513.
27. Stojadinovic, A., J. Kiang, R. Smallridge, R. Galloway, and T. Shea-Donohue. 1995. Induction of heat-shock protein 72 protects against ischemia/reperfusion in rat small intestine. Gastroenterology 109:505.
28. Miner, T. J., H. Tavaf-Motamen, A. Stojadinovic, and T. Shea-Donohue. 1999. Ischemia-reperfusion protects the rat small intestine against subsequent injury. J. Surg. Res. 82:1.
29. Eror, A. T., A. Stojadinovic, B. W. Starnes, S. C. Makrides, G. C. Tsokos, and T. Shea-Donohue. 1999. Anti-inflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin. Immunol. 90:266.
30. Speyer, C. L., T. A. Neff, R. L. Warner, R. F. Guo, J. V. Sarma, N. C. Riedemann, M. E. Murphy, H. S. Murphy, and P. A. Ward. 2003. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am. J. Pathol. 163:2319.
31. Warren, R. W., S. A. Caster, J. B. Roths, E. D. Murphy, and D. S. Pisetsky. 1984. The influence f the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin. Immunol. Immunopathol. 31:65.
32. Haas, K. M., M. Hasegawa, D. A. Steeber, J. C. Poe, M. D. Zabel, C. B. Bock, D. R. Karp, D. E. Briles, J. H. Weis, and T. F. Tedder. 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17:713.
33. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
34. Izui, S., V. E. Kelley, and K. Masuda. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
35. Radic, M., T. Marion, and M. Monestier. 2004. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 172:6692.
36. Farber, A., J. P. Connors, R. M. Friedlander, R. J. Wagner, R. J. Powell, and J. L. Cronenwett. 1999. A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice. J. Vasc. Surg. 30:752.
37. Coopersmith, C. M., D. O'Donnell, and J. I. Gordon. 1999. Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice. Am. J. Physiol. 276:G677.
38. DeGiorgio, L. A., K. N. Konstantinov, S. C. Lee, J. A. Hardin, B. T. Volpe, and B. Diamond. 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7:1189.
39. Shlomchik, M. J., and M. P. Madaio. 2003. The role of antibodies and B cells in the pathogenesis of lupus nephritis. Springer Semin. Immunopathol. 24:363.
40. Holers, V. M., G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando, and J. E. Salmon. 2002. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195:211.
41. Salmon, J. E., G. Girardi, and V. M. Holers. 2003. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 12:535.
42. Salmon, J. E., G. Girardi, and V. M. Holers. 2002. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann. Rheum. Dis. 61(Suppl. 2):ii46.